-
external
In the Media
PR Newswire: Trevi Therapeutics Announces Appointment of James V. Cassella, Ph.D., as Chief Development Officer
September 30, 2024
James V. Cassella ’76, Ph.D., was named chief development officer at Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company
https://www.prnewswire.com/news-releases/trevi-therapeutics-announces-appointment-of-james-v-cassella-phd-as-chief-development-officer-302263194.html
pr-newswire-logo
news-all
news-in-the-media
year-2024
month-september
name-pr-newswire-logo